Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study. - Conteduca, V.; Wetterskog, D.; Sharabiani, M. T. A.; Grande, E.; Fernandez-Perez, M. P.; Jayaram, A.; Salvi, S.; Castellano, D.; Romanel, A.; Lolli, C.; Casadio, V.; Gurioli, G.; et al. (Annals of Oncology, 2017)